MR imaging and targeting of a specific alveolar macrophage subpopulation in LPS-induced COPD animal model using antibody-conjugated magnetic nanoparticles

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 1491-1503

  Faraj, Achraf Al ^a   Shaik, Asma Sultana ^a   Afzal, Sibtain ^b   Sayed, Baraa Al ^a   Halwani, Rabih ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Iron oxide nanoparticles; Lipopolysaccharide; Lung imaging; Lung inflammation; Macrophage tracking; Magnetic resonance imaging; MRI

Indexed keywords

ARGONAUTE 1 PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CELL DIFFERENTIATION; CELL INFILTRATION; CELL POPULATION; CELLULAR DISTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PROTOCOL; CONJUGATION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MACROPHAGE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION;

IRON OXIDE NANOPARTICLES; LIPOPOLYSACCHARIDE; LUNG IMAGING; LUNG INFLAMMATION; MACROPHAGE TRACKING; MAGNETIC RESONANCE IMAGING; MRI;

ANIMALS; ANTIBODIES; CELL TRACKING; CONTRAST MEDIA; DEXTRANS; FEMALE; LIPOPOLYSACCHARIDES; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICE; MICE, INBRED BALB C; PULMONARY ALVEOLI; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84897093479     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S59394     Document Type: Article

References (42)

1. Smith I, Schallenberg, M. Occurrence of the agricultural nitrification inhibitor, dicyandiamide, in surface waters and its effects on nitrogen dynamics in an experimental aquatic system. Agric Ecosyst Environ. 2013;164:23-31.
2. Barnes P. Alveolar macrophages as orchestrators of COPD. COPD. 2004;1(1):59-70.
3. Alber A, Howie SE, Wallace WA, Hirani N. The role of macrophages in healing the wounded lung. Int J Exp Pathol. 2012;93(4):243-251.
4. Herold S, Mayer K, Lohmeyer J. Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair. Front Immunol. 2011;2:65.
5. Duan M, Li WC, Vlahos R, Maxwell MJ, Anderson GP, Hibbs ML. Distinct macrophage subpopulations characterize acute infection and chronic inflammatory lung disease. J Immunol. 2012;189(2): 946-955.
6. Weissleder R. Molecular imaging in cancer. Science. 2006;312(5777): 1168-1171.
7. McCarthy JR, Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev. 2008;60(11): 1241-1251.
8. Oghabian MA, Farahbakhsh NM. Potential use of nanoparticle based contrast agents in MRI: a molecular imaging perspective. J Biomed Nanotechnol. 2010;6(3):203-213.
9. Tassa C, Shaw SY, Weissleder R. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc Chem Res. 2011;44(10):842-852.
10. Jokerst JV, Gambhir SS. Molecular imaging with theranostic nanoparticles. Acc Chem Res. 2011;44(10):1050-1060.
11. Modo MMJ, Bulte JWM. Molecular and Cellular MR Imaging. CRC Press; 2007.
12. Beckmann N, Cannet C, Babin AL, et al. In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1(3):272-298.
13. Tyler DJ, Robson MD, Henkelman RM, Young IR, Bydder GM. Magnetic resonance imaging with ultrashort TE (UTE) PULSE sequences: technical considerations. J Magn Reson Imaging. 2007;25(2):279-289.
14. Zurek M, Boyer L, Caramelle P, Boczkowski J, Cremillieux Y. Longitudinal and noninvasive assessment of emphysema evolution in a murine model using proton MRI. Magn Reson Med. 2012;68(3): 898-904.
15. Al Faraj A, Luciani N, Kolosnjaj-Tabi J, et al. Real-time high-resolution magnetic resonance tracking of macrophage subpopulations in a murine inflammation model: a pilot study with a commercially available cryogenic probe. Contrast Media Mol Imaging. 2013;8(2):193-203.
16. Al Faraj A. Preferential magnetic nanoparticle uptake by bone marrow derived macrophages sub-populations: effect of surface coating on polarization, toxicity, and in vivo MRI detection. J Nanopart Res. 2013;15(7):1-13.
17. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2009;27:451-483.
18. Shahbazi-Gahrouei D, Abdolahi M, Zarkesh-Esfahani SH, Laurent S, Sermeus C, Gruettner C. Functionalized magnetic nanoparticles for the detection and quantitative analysis of cell surface antigen. Biomed Res Int. 2013;2013:349408.
19. Rimkus G, Bremer-Streck S, Grüttner C, Kaiser WA, Hilger I. Can we accurately quantify nanoparticle associated proteins when constructing high-affinity MRI molecular imaging probes? Contrast Media Mol Imaging. 2011;6(3):119-125.
20. Al Faraj A, Bessaad A, Cieslar K, Lacroix G, Canet-Soulas E, Cremillieux Y. Long-term follow-up of lung biodistribution and effect of instilled SWCNTs using multiscale imaging techniques. Nanotechnology. 2010;21(17):175103.
21. Vazquez-Tello A, Halwani R, Li R, et al. IL-17A and IL-17F expression in B lymphocytes. Int Arch Allergy Immunol. 2012;157(4):406-416.
22. Richards JM, Shaw CA, Lang NN, et al. In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humans. Circ Cardiovasc Imaging. 2012;5(4):509-517.
23. Arbab AS, Janic B, Haller J, Pawelczyk E, Liu W, Frank JA. In vivo cellular imaging for translational medical research. Curr Med Imaging Rev. 2009;5(1):19-38.
24. Wright JL, Cosio M, Churg A. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2008;295(1): L1-L15.
25. Korsgren M, Linden M, Entwistle N, et al. Inhalation of LPS induces inflammatory airway responses mimicking characteristics of chronic obstructive pulmonary disease. Clin Physiol Funct Imaging. 2012;32(1):71-79.
26. Kharitonov SA, Sjobring U. Lipopolysaccharide challenge of humans as a model for chronic obstructive lung disease exacerbations. Contrib Microbiol. 2007;14:83-100.
27. Shapiro SD. Animal models for COPD. Chest. 2000;117(5 Suppl 1): 223S-227S.
28. Alm AS, Li K, Chen H, Wang D, Andersson R, Wang X. Variation of lipopolysaccharide-induced acute lung injury in eight strains of mice. Respir Physiol Neurobiol. 2010;171(2):157-164.
29. Hakansson HF, Smailagic A, Brunmark C, Miller-Larsson A, Lal H. Altered lung function relates to inflammation in an acute LPS mouse model. Pulm Pharmacol Ther. 2012;25(5):399-406.
30. Olsson LE, Smailagic A, Onnervik PO, Hockings PD. (1)H and hyperpolarized (3)He MR imaging of mouse with LPS-induced inflammation. J Magn Reson Imaging. 2009;29(4):977-981.
31. Beckmann N, Tigani B, Sugar R, et al. Noninvasive detection of endotoxin-induced mucus hypersecretion in rat lung by MRI. Am J Physiol Lung Cell Mol Physiol. 2002;283(1):L22-L30.
32. Card JW, Zeldin DC, Bonner JC, Nestmann ER. Pulmonary applications and toxicity of engineered nanoparticles. Am J Physiol Lung Cell Mol Physiol. 2008;295(3):L400-L411.
33. Pusic K, Aguilar Z, McLoughlin J, et al. Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine. FASEB J. 2013 2013;27(3):1153-1166.
34. Barnes PJ. The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2009;41(6):631-638.
35. Grenha A, Grainger CI, Dailey LA, et al. Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro. Eur J Pharm Sci. 2007;31(2):73-84.
36. Huang J, Zhong X, Wang L, Yang L, Mao H. Improving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticles. Theranostics. 2012;2(1):86-102.
37. Tong S, Hou S, Zheng Z, Zhou J, Bao G. Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity. Nano Lett. 2010;10(11):4607-4613.
38. Wang YX. Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant Imaging Med Surg. 2011;1(1):35-40.
39. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40(11):715-724.
40. Beckmann N, Tigani B, Mazzoni L, Fozard JR. MRI of lung parenchyma in rats and mice using a gradient-echo sequence. NMR Biomed. 2001;14(5):297-306.
41. Togao O, Tsuji R, Ohno Y, Dimitrov I, Takahashi M. Ultrashort echo time (UTE) MRI of the lung: assessment of tissue density in the lung parenchyma. Magn Reson Med. Nov 2010;64(5):1491-1498.
42. Conti G, Tambalo S, Villetti G, et al. Evaluation of lung inflammation induced by intratracheal administration of LPS in mice: comparison between MRI and histology. MAGMA. 2010;23(2):93-101.